Results
Camlin Fine Sciences Q2FY27 EBITDA Margin 0.45%
Camlin Fine Sciences reported Q2FY27 revenue of ₹4,915 mn, up 9.15% YoY, but EBITDA plummeted to ₹22.3 mn with a 0.45% margin due to high raw material costs and operational issues.
The company acquire
